SALIM VIRANI to Clinical Trials as Topic
This is a "connection" page, showing publications SALIM VIRANI has written about Clinical Trials as Topic.
Connection Strength
1.103
-
The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Curr Probl Cardiol. 2025 Jan; 50(1):102922.
Score: 0.172
-
Ongoing and future clinical trials of device therapies for patients with heart failure. Curr Probl Cardiol. 2024 Nov; 49(11):102805.
Score: 0.169
-
Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure. Am J Cardiovasc Drugs. 2024 Jul; 24(4):481-504.
Score: 0.167
-
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Curr Atheroscler Rep. 2020 10 03; 22(12):72.
Score: 0.129
-
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
Score: 0.116
-
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
Score: 0.115
-
The Role of Ezetimibe in the Treatment of Cardiovascular Disease. Curr Atheroscler Rep. 2016 Feb; 18(2):8.
Score: 0.094
-
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future. Curr Opin Lipidol. 2010 Apr; 21(2):165-6.
Score: 0.062
-
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis. Curr Atheroscler Rep. 2007 Aug; 9(2):97-103.
Score: 0.052
-
Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome: An NCDR Research to Practice Project. JAMA Intern Med. 2017 06 01; 177(6):887-889.
Score: 0.026